COMPANIES COVERED
GlaxoSmithKlineDownload FREE Report Sample
Download Free sampleAsthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.
Anti Asthma Drugs Market contains market size and forecasts of Anti Asthma Drugs in global, including the following market information:
Global Anti Asthma Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anti Asthma Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti Asthma Drugs companies in 2021 (%)
The global Anti Asthma Drugs market was valued at 21520 million in 2021 and is projected to reach US$ 26930 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bronchodilators Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti Asthma Drugs include GlaxoSmithKline, Merck & Co, AstraZeneca, F. Hoffmann-La Roche, Teva Pharmaceutical, Novartis International, Boehringer Ingelheim and Sunovion Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti Asthma Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti Asthma Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti Asthma Drugs Market Segment Percentages, by Type, 2021 (%)
Bronchodilators
Leukotriene Antagonists
Mast Cell Stabilizers
Corticosteroids
Monoclonal Antibody
Global Anti Asthma Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti Asthma Drugs Market Segment Percentages, by Application, 2021 (%)
Clinics
Hospitals
Other
Global Anti Asthma Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti Asthma Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti Asthma Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anti Asthma Drugs revenues share in global market, 2021 (%)
Key companies Anti Asthma Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anti Asthma Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck & Co
AstraZeneca
F. Hoffmann-La Roche
Teva Pharmaceutical
Novartis International
Boehringer Ingelheim
Sunovion Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
